
Selecta Biosciences (SELB) Stock Forecast & Price Target
Selecta Biosciences (SELB) Analyst Ratings
Based on 10 analyst ratings
Strong Buy
Strong Buy 80%
Buy 10%
Hold 10%
Sell 0%
Strong Sell 0%
Selecta Biosciences (SELB) has been analyzed by 10 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 10% recommend Buy, 10% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Selecta Biosciences and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Selecta Biosciences and is not a guaranteed prediction by Public.com or investment advice.
Selecta Biosciences (SELB) Analyst Forecast & Price Prediction
Get the latest Selecta Biosciences (SELB) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Selecta Biosciences (SELB)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Selecta Biosciences (SELB) Forecast
Analysts have given Selecta Biosciences (SELB) a Strong Buy based on their latest research and market trends.
According to 10 analysts, Selecta Biosciences (SELB) has a Strong Buy consensus rating as of Jun 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $11.80, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $11.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.